nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0256	0.0344	CbGbCtD
Progesterone—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0221	0.0297	CbGbCtD
Progesterone—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.022	0.0296	CbGbCtD
Progesterone—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0204	0.0275	CbGbCtD
Progesterone—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0194	0.0261	CbGbCtD
Progesterone—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0194	0.0261	CbGbCtD
Progesterone—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0174	0.0234	CbGbCtD
Progesterone—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0169	0.0227	CbGbCtD
Progesterone—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0168	0.0227	CbGbCtD
Progesterone—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0153	0.0206	CbGbCtD
Progesterone—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0144	0.0194	CbGbCtD
Progesterone—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0134	0.0181	CbGbCtD
Progesterone—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.013	0.0176	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0126	0.017	CbGbCtD
Progesterone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0126	0.017	CbGbCtD
Progesterone—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0113	0.0152	CbGbCtD
Progesterone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0109	0.0147	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0109	0.0147	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0143	CbGbCtD
Progesterone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0143	CbGbCtD
Progesterone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0105	0.0141	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00957	0.0129	CbGbCtD
Progesterone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00957	0.0129	CbGbCtD
Progesterone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00957	0.0129	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00957	0.0129	CbGbCtD
Progesterone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00947	0.0128	CbGbCtD
Progesterone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00947	0.0128	CbGbCtD
Progesterone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00911	0.0123	CbGbCtD
Progesterone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00911	0.0123	CbGbCtD
Progesterone—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00899	0.0121	CbGbCtD
Progesterone—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00845	0.0114	CbGbCtD
Progesterone—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00829	0.0112	CbGbCtD
Progesterone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00818	0.011	CbGbCtD
Progesterone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00794	0.0107	CbGbCtD
Progesterone—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0078	0.0105	CbGbCtD
Progesterone—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0078	0.0105	CbGbCtD
Progesterone—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00764	0.0103	CbGbCtD
Progesterone—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00764	0.0103	CbGbCtD
Progesterone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00747	0.0101	CbGbCtD
Progesterone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00718	0.00968	CbGbCtD
Progesterone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00718	0.00968	CbGbCtD
Progesterone—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00705	0.0095	CbGbCtD
Progesterone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00703	0.00947	CbGbCtD
Progesterone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00703	0.00947	CbGbCtD
Progesterone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0069	0.00931	CbGbCtD
Progesterone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0069	0.00931	CbGbCtD
Progesterone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00683	0.00921	CbGbCtD
Progesterone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00682	0.00919	CbGbCtD
Progesterone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00662	0.00892	CbGbCtD
Progesterone—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0066	0.00889	CbGbCtD
Progesterone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00642	0.00866	CbGbCtD
Progesterone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00642	0.00866	CbGbCtD
Progesterone—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0064	0.00863	CbGbCtD
Progesterone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00635	0.00856	CbGbCtD
Progesterone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00635	0.00856	CbGbCtD
Progesterone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00617	0.00831	CbGbCtD
Progesterone—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00591	0.00797	CbGbCtD
Progesterone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00581	0.00783	CbGbCtD
Progesterone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00581	0.00783	CbGbCtD
Progesterone—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00579	0.00781	CbGbCtD
Progesterone—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00579	0.00781	CbGbCtD
Progesterone—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00555	0.00748	CbGbCtD
Progesterone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00548	0.00739	CbGbCtD
Progesterone—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00534	0.0072	CbGbCtD
Progesterone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00532	0.00718	CbGbCtD
Progesterone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00532	0.00717	CbGbCtD
Progesterone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00517	0.00696	CbGbCtD
Progesterone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00502	0.00676	CbGbCtD
Progesterone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00487	0.00656	CbGbCtD
Progesterone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00482	0.00649	CbGbCtD
Progesterone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00482	0.00649	CbGbCtD
Progesterone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00467	0.0063	CbGbCtD
Progesterone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.0063	CbGbCtD
Progesterone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00462	0.00622	CbGbCtD
Progesterone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00448	0.00604	CbGbCtD
Progesterone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0044	0.00594	CbGbCtD
Progesterone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0044	0.00594	CbGbCtD
Progesterone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00435	0.00586	CbGbCtD
Progesterone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00409	0.00551	CbGbCtD
Progesterone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00409	0.00551	CbGbCtD
Progesterone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00369	0.00498	CbGbCtD
Progesterone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00369	0.00498	CbGbCtD
Progesterone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00347	0.00467	CbGbCtD
Progesterone—SHBG—semen—acquired immunodeficiency syndrome	0.0033	0.0593	CbGeAlD
Progesterone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00319	0.0043	CbGbCtD
Progesterone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0031	0.00417	CbGbCtD
Progesterone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0028	0.00377	CbGbCtD
Progesterone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0028	0.00377	CbGbCtD
Progesterone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00268	0.00362	CbGbCtD
Progesterone—AR—semen—acquired immunodeficiency syndrome	0.00237	0.0425	CbGeAlD
Progesterone—SHBG—blood plasma—acquired immunodeficiency syndrome	0.0012	0.0216	CbGeAlD
Progesterone—NR3C2—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0209	CbGeAlD
Progesterone—NR3C1—nerve—acquired immunodeficiency syndrome	0.000828	0.0148	CbGeAlD
Progesterone—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000801	0.0144	CbGeAlD
Progesterone—SLC10A1—digestive system—acquired immunodeficiency syndrome	0.000713	0.0128	CbGeAlD
Progesterone—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000705	0.0126	CbGeAlD
Progesterone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000699	0.0125	CbGeAlD
Progesterone—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000654	0.0117	CbGeAlD
Progesterone—NR3C2—retina—acquired immunodeficiency syndrome	0.000639	0.0115	CbGeAlD
Progesterone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000631	0.0113	CbGeAlD
Progesterone—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.000626	0.0112	CbGeAlD
Progesterone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000621	0.0111	CbGeAlD
Progesterone—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000565	0.0101	CbGeAlD
Progesterone—SLC10A1—nervous system—acquired immunodeficiency syndrome	0.000551	0.00989	CbGeAlD
Progesterone—SLC10A1—central nervous system—acquired immunodeficiency syndrome	0.000531	0.00952	CbGeAlD
Progesterone—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000486	0.00871	CbGeAlD
Progesterone—CYP17A1—nervous system—acquired immunodeficiency syndrome	0.00048	0.00861	CbGeAlD
Progesterone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000473	0.00849	CbGeAlD
Progesterone—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000468	0.00839	CbGeAlD
Progesterone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000466	0.00835	CbGeAlD
Progesterone—CYP17A1—central nervous system—acquired immunodeficiency syndrome	0.000462	0.00829	CbGeAlD
Progesterone—NR3C2—digestive system—acquired immunodeficiency syndrome	0.000449	0.00805	CbGeAlD
Progesterone—SHBG—blood—acquired immunodeficiency syndrome	0.000441	0.00791	CbGeAlD
Progesterone—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000439	0.00787	CbGeAlD
Progesterone—NR3C2—blood—acquired immunodeficiency syndrome	0.000427	0.00767	CbGeAlD
Progesterone—SHBG—bone marrow—acquired immunodeficiency syndrome	0.000427	0.00765	CbGeAlD
Progesterone—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000423	0.00758	CbGeAlD
Progesterone—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.000422	0.00757	CbGeAlD
Progesterone—SLC10A1—brain—acquired immunodeficiency syndrome	0.000421	0.00756	CbGeAlD
Progesterone—AR—skin of body—acquired immunodeficiency syndrome	0.000415	0.00745	CbGeAlD
Progesterone—NR3C2—spinal cord—acquired immunodeficiency syndrome	0.000412	0.00739	CbGeAlD
Progesterone—SHBG—vagina—acquired immunodeficiency syndrome	0.000409	0.00733	CbGeAlD
Progesterone—CYP2A6—lung—acquired immunodeficiency syndrome	0.0004	0.00717	CbGeAlD
Progesterone—PGR—blood—acquired immunodeficiency syndrome	0.000397	0.00713	CbGeAlD
Progesterone—NR3C2—vagina—acquired immunodeficiency syndrome	0.000396	0.00711	CbGeAlD
Progesterone—SLC22A1—blood—acquired immunodeficiency syndrome	0.000381	0.00682	CbGeAlD
Progesterone—NR3C2—lung—acquired immunodeficiency syndrome	0.000375	0.00672	CbGeAlD
Progesterone—OPRK1—brain—acquired immunodeficiency syndrome	0.000371	0.00666	CbGeAlD
Progesterone—PGR—vagina—acquired immunodeficiency syndrome	0.000368	0.00661	CbGeAlD
Progesterone—CYP17A1—brain—acquired immunodeficiency syndrome	0.000367	0.00658	CbGeAlD
Progesterone—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000355	0.00637	CbGeAlD
Progesterone—CYP17A1—lymph node—acquired immunodeficiency syndrome	0.000355	0.00636	CbGeAlD
Progesterone—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000353	0.00633	CbGeAlD
Progesterone—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000352	0.0063	CbGeAlD
Progesterone—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000351	0.00629	CbGeAlD
Progesterone—PGR—lung—acquired immunodeficiency syndrome	0.000348	0.00625	CbGeAlD
Progesterone—NR3C2—nervous system—acquired immunodeficiency syndrome	0.000347	0.00622	CbGeAlD
Progesterone—SHBG—central nervous system—acquired immunodeficiency syndrome	0.000345	0.00618	CbGeAlD
Progesterone—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.00034	0.0061	CbGeAlD
Progesterone—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000339	0.00607	CbGeAlD
Progesterone—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000337	0.00605	CbGeAlD
Progesterone—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000336	0.00603	CbGeAlD
Progesterone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000335	0.00601	CbGeAlD
Progesterone—CYP1B1—blood—acquired immunodeficiency syndrome	0.000334	0.00599	CbGeAlD
Progesterone—NR3C2—central nervous system—acquired immunodeficiency syndrome	0.000334	0.00599	CbGeAlD
Progesterone—AR—digestive system—acquired immunodeficiency syndrome	0.000332	0.00596	CbGeAlD
Progesterone—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00033	0.00592	CbGeAlD
Progesterone—ESR1—digestive system—acquired immunodeficiency syndrome	0.000326	0.00585	CbGeAlD
Progesterone—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000326	0.00584	CbGeAlD
Progesterone—PGR—nervous system—acquired immunodeficiency syndrome	0.000323	0.00578	CbGeAlD
Progesterone—SLC22A3—lung—acquired immunodeficiency syndrome	0.000319	0.00572	CbGeAlD
Progesterone—AR—blood—acquired immunodeficiency syndrome	0.000317	0.00568	CbGeAlD
Progesterone—ESR1—blood—acquired immunodeficiency syndrome	0.000311	0.00557	CbGeAlD
Progesterone—PGR—central nervous system—acquired immunodeficiency syndrome	0.000311	0.00557	CbGeAlD
Progesterone—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.00031	0.00556	CbGeAlD
Progesterone—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000309	0.00554	CbGeAlD
Progesterone—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000308	0.00553	CbGeAlD
Progesterone—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000308	0.00552	CbGeAlD
Progesterone—AR—spinal cord—acquired immunodeficiency syndrome	0.000305	0.00547	CbGeAlD
Progesterone—NR3C1—skin of body—acquired immunodeficiency syndrome	0.000301	0.0054	CbGeAlD
Progesterone—ABCC1—blood—acquired immunodeficiency syndrome	0.000301	0.00539	CbGeAlD
Progesterone—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000297	0.00533	CbGeAlD
Progesterone—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000295	0.00529	CbGeAlD
Progesterone—AR—vagina—acquired immunodeficiency syndrome	0.000293	0.00526	CbGeAlD
Progesterone—CYP2C19—blood—acquired immunodeficiency syndrome	0.000293	0.00526	CbGeAlD
Progesterone—CYP1B1—lung—acquired immunodeficiency syndrome	0.000293	0.00526	CbGeAlD
Progesterone—ESR1—vagina—acquired immunodeficiency syndrome	0.000288	0.00517	CbGeAlD
Progesterone—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000284	0.0051	CbGeAlD
Progesterone—CYP2A6—brain—acquired immunodeficiency syndrome	0.000283	0.00507	CbGeAlD
Progesterone—ABCC1—vagina—acquired immunodeficiency syndrome	0.000279	0.005	CbGeAlD
Progesterone—AR—lung—acquired immunodeficiency syndrome	0.000278	0.00498	CbGeAlD
Progesterone—SHBG—brain—acquired immunodeficiency syndrome	0.000274	0.00491	CbGeAlD
Progesterone—ESR1—lung—acquired immunodeficiency syndrome	0.000272	0.00489	CbGeAlD
Progesterone—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000272	0.00488	CbGeAlD
Progesterone—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000271	0.00487	CbGeAlD
Progesterone—NR3C2—brain—acquired immunodeficiency syndrome	0.000265	0.00476	CbGeAlD
Progesterone—ABCC1—lung—acquired immunodeficiency syndrome	0.000264	0.00473	CbGeAlD
Progesterone—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000261	0.00469	CbGeAlD
Progesterone—AR—nervous system—acquired immunodeficiency syndrome	0.000257	0.00461	CbGeAlD
Progesterone—NR3C2—lymph node—acquired immunodeficiency syndrome	0.000256	0.0046	CbGeAlD
Progesterone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000256	0.00459	CbGeAlD
Progesterone—ESR1—nervous system—acquired immunodeficiency syndrome	0.000252	0.00452	CbGeAlD
Progesterone—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000251	0.00451	CbGeAlD
Progesterone—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000248	0.00445	CbGeAlD
Progesterone—AR—central nervous system—acquired immunodeficiency syndrome	0.000247	0.00444	CbGeAlD
Progesterone—PGR—brain—acquired immunodeficiency syndrome	0.000247	0.00442	CbGeAlD
Progesterone—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000244	0.00437	CbGeAlD
Progesterone—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000243	0.00436	CbGeAlD
Progesterone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000243	0.00435	CbGeAlD
Progesterone—NR3C1—digestive system—acquired immunodeficiency syndrome	0.000241	0.00432	CbGeAlD
Progesterone—CYP1A2—blood—acquired immunodeficiency syndrome	0.00024	0.0043	CbGeAlD
Progesterone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000239	0.00428	CbGeAlD
Progesterone—PGR—lymph node—acquired immunodeficiency syndrome	0.000238	0.00427	CbGeAlD
Progesterone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000237	0.00426	CbGeAlD
Progesterone—CYP1A1—blood—acquired immunodeficiency syndrome	0.000236	0.00424	CbGeAlD
Progesterone—SLC22A1—brain—acquired immunodeficiency syndrome	0.000236	0.00423	CbGeAlD
Progesterone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000231	0.00414	CbGeAlD
Progesterone—NR3C1—blood—acquired immunodeficiency syndrome	0.000229	0.00411	CbGeAlD
Progesterone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000227	0.00408	CbGeAlD
Progesterone—SLC22A3—brain—acquired immunodeficiency syndrome	0.000226	0.00405	CbGeAlD
Progesterone—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.000222	0.00398	CbGeAlD
Progesterone—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.000221	0.00396	CbGeAlD
Progesterone—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000219	0.00393	CbGeAlD
Progesterone—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000218	0.00391	CbGeAlD
Progesterone—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000218	0.00391	CbGeAlD
Progesterone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000214	0.00384	CbGeAlD
Progesterone—NR3C1—vagina—acquired immunodeficiency syndrome	0.000213	0.00381	CbGeAlD
Progesterone—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000211	0.00378	CbGeAlD
Progesterone—CYP1A2—lung—acquired immunodeficiency syndrome	0.00021	0.00377	CbGeAlD
Progesterone—CYP1B1—brain—acquired immunodeficiency syndrome	0.000207	0.00372	CbGeAlD
Progesterone—CYP1A1—lung—acquired immunodeficiency syndrome	0.000207	0.00372	CbGeAlD
Progesterone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000203	0.00363	CbGeAlD
Progesterone—NR3C1—lung—acquired immunodeficiency syndrome	0.000201	0.0036	CbGeAlD
Progesterone—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.0002	0.00359	CbGeAlD
Progesterone—AR—brain—acquired immunodeficiency syndrome	0.000196	0.00352	CbGeAlD
Progesterone—ESR1—brain—acquired immunodeficiency syndrome	0.000193	0.00346	CbGeAlD
Progesterone—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000192	0.00344	CbGeAlD
Progesterone—AR—lymph node—acquired immunodeficiency syndrome	0.00019	0.0034	CbGeAlD
Progesterone—ABCC1—brain—acquired immunodeficiency syndrome	0.000187	0.00335	CbGeAlD
Progesterone—ESR1—lymph node—acquired immunodeficiency syndrome	0.000186	0.00334	CbGeAlD
Progesterone—NR3C1—nervous system—acquired immunodeficiency syndrome	0.000186	0.00334	CbGeAlD
Progesterone—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000185	0.00331	CbGeAlD
Progesterone—ABCB1—retina—acquired immunodeficiency syndrome	0.000183	0.00329	CbGeAlD
Progesterone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000182	0.00326	CbGeAlD
Progesterone—ABCC1—lymph node—acquired immunodeficiency syndrome	0.00018	0.00323	CbGeAlD
Progesterone—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.000179	0.00321	CbGeAlD
Progesterone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000179	0.00321	CbGeAlD
Progesterone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000173	0.00311	CbGeAlD
Progesterone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000171	0.00306	CbGeAlD
Progesterone—CYP2C8—brain—acquired immunodeficiency syndrome	0.000159	0.00285	CbGeAlD
Progesterone—CYP1A1—brain—acquired immunodeficiency syndrome	0.000147	0.00263	CbGeAlD
Progesterone—NR3C1—brain—acquired immunodeficiency syndrome	0.000142	0.00255	CbGeAlD
Progesterone—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000142	0.00254	CbGeAlD
Progesterone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000141	0.00252	CbGeAlD
Progesterone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000139	0.00248	CbGeAlD
Progesterone—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000137	0.00247	CbGeAlD
Progesterone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000136	0.00243	CbGeAlD
Progesterone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000133	0.00239	CbGeAlD
Progesterone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.00013	0.00234	CbGeAlD
Progesterone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000129	0.00231	CbGeAlD
Progesterone—ABCB1—blood—acquired immunodeficiency syndrome	0.000123	0.0022	CbGeAlD
Progesterone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000119	0.00213	CbGeAlD
Progesterone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000118	0.00212	CbGeAlD
Progesterone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000114	0.00204	CbGeAlD
Progesterone—ABCB1—lung—acquired immunodeficiency syndrome	0.000108	0.00193	CbGeAlD
Progesterone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000106	0.0019	CbGeAlD
Progesterone—ABCB1—nervous system—acquired immunodeficiency syndrome	9.96e-05	0.00179	CbGeAlD
Progesterone—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.59e-05	0.00172	CbGeAlD
Progesterone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.000423	CcSEcCtD
Progesterone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000423	CcSEcCtD
Progesterone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000423	CcSEcCtD
Progesterone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000422	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	8.49e-05	0.000421	CcSEcCtD
Progesterone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	8.47e-05	0.00042	CcSEcCtD
Progesterone—Pruritus—Abacavir—acquired immunodeficiency syndrome	8.46e-05	0.000419	CcSEcCtD
Progesterone—Fatigue—Indinavir—acquired immunodeficiency syndrome	8.45e-05	0.000419	CcSEcCtD
Progesterone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	8.45e-05	0.000419	CcSEcCtD
Progesterone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	8.45e-05	0.000419	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	8.44e-05	0.000419	CcSEcCtD
Progesterone—Cough—Saquinavir—acquired immunodeficiency syndrome	8.44e-05	0.000418	CcSEcCtD
Progesterone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.000418	CcSEcCtD
Progesterone—Pain—Indinavir—acquired immunodeficiency syndrome	8.39e-05	0.000416	CcSEcCtD
Progesterone—Constipation—Indinavir—acquired immunodeficiency syndrome	8.39e-05	0.000416	CcSEcCtD
Progesterone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	8.38e-05	0.000416	CcSEcCtD
Progesterone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	8.38e-05	0.000416	CcSEcCtD
Progesterone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	8.38e-05	0.000416	CcSEcCtD
Progesterone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.000415	CcSEcCtD
Progesterone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	8.35e-05	0.000414	CcSEcCtD
Progesterone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	8.34e-05	0.000413	CcSEcCtD
Progesterone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	8.34e-05	0.000413	CcSEcCtD
Progesterone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	8.33e-05	0.000413	CcSEcCtD
Progesterone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	8.32e-05	0.000413	CcSEcCtD
Progesterone—Malaise—Lamivudine—acquired immunodeficiency syndrome	8.32e-05	0.000413	CcSEcCtD
Progesterone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	8.3e-05	0.000412	CcSEcCtD
Progesterone—Nausea—Didanosine—acquired immunodeficiency syndrome	8.3e-05	0.000412	CcSEcCtD
Progesterone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	8.29e-05	0.000411	CcSEcCtD
Progesterone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	8.28e-05	0.000411	CcSEcCtD
Progesterone—Syncope—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.00041	CcSEcCtD
Progesterone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.00041	CcSEcCtD
Progesterone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	8.26e-05	0.00041	CcSEcCtD
Progesterone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	8.24e-05	0.000409	CcSEcCtD
Progesterone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000408	CcSEcCtD
Progesterone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000408	CcSEcCtD
Progesterone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000408	CcSEcCtD
Progesterone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.000407	CcSEcCtD
Progesterone—Oedema—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000407	CcSEcCtD
Progesterone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	8.18e-05	0.000406	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.17e-05	0.000405	CcSEcCtD
Progesterone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.000405	CcSEcCtD
Progesterone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	8.13e-05	0.000403	CcSEcCtD
Progesterone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000402	CcSEcCtD
Progesterone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	8.08e-05	0.000401	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	8.08e-05	0.000401	CcSEcCtD
Progesterone—Shock—Ritonavir—acquired immunodeficiency syndrome	8.07e-05	0.0004	CcSEcCtD
Progesterone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.0004	CcSEcCtD
Progesterone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000399	CcSEcCtD
Progesterone—Cough—Lamivudine—acquired immunodeficiency syndrome	8.05e-05	0.000399	CcSEcCtD
Progesterone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	8.05e-05	0.000399	CcSEcCtD
Progesterone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000399	CcSEcCtD
Progesterone—Dizziness—Stavudine—acquired immunodeficiency syndrome	8.02e-05	0.000398	CcSEcCtD
Progesterone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	8.02e-05	0.000398	CcSEcCtD
Progesterone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	8.02e-05	0.000398	CcSEcCtD
Progesterone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	8e-05	0.000397	CcSEcCtD
Progesterone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	8e-05	0.000397	CcSEcCtD
Progesterone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000396	CcSEcCtD
Progesterone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.99e-05	0.000396	CcSEcCtD
Progesterone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.99e-05	0.000396	CcSEcCtD
Progesterone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.96e-05	0.000395	CcSEcCtD
Progesterone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.96e-05	0.000395	CcSEcCtD
Progesterone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000395	CcSEcCtD
Progesterone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000393	CcSEcCtD
Progesterone—Pain—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000393	CcSEcCtD
Progesterone—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000393	CcSEcCtD
Progesterone—Rash—Nevirapine—acquired immunodeficiency syndrome	7.92e-05	0.000393	CcSEcCtD
Progesterone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.92e-05	0.000393	CcSEcCtD
Progesterone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.9e-05	0.000392	CcSEcCtD
Progesterone—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.9e-05	0.000392	CcSEcCtD
Progesterone—Oedema—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000391	CcSEcCtD
Progesterone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.88e-05	0.000391	CcSEcCtD
Progesterone—Headache—Nevirapine—acquired immunodeficiency syndrome	7.87e-05	0.00039	CcSEcCtD
Progesterone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.00039	CcSEcCtD
Progesterone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.00039	CcSEcCtD
Progesterone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.00039	CcSEcCtD
Progesterone—Infection—Saquinavir—acquired immunodeficiency syndrome	7.84e-05	0.000389	CcSEcCtD
Progesterone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.83e-05	0.000388	CcSEcCtD
Progesterone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.81e-05	0.000388	CcSEcCtD
Progesterone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.000387	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.8e-05	0.000387	CcSEcCtD
Progesterone—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.79e-05	0.000386	CcSEcCtD
Progesterone—Shock—Saquinavir—acquired immunodeficiency syndrome	7.76e-05	0.000385	CcSEcCtD
Progesterone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000385	CcSEcCtD
Progesterone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.75e-05	0.000385	CcSEcCtD
Progesterone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.75e-05	0.000385	CcSEcCtD
Progesterone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000384	CcSEcCtD
Progesterone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.74e-05	0.000384	CcSEcCtD
Progesterone—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.71e-05	0.000383	CcSEcCtD
Progesterone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.71e-05	0.000382	CcSEcCtD
Progesterone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000381	CcSEcCtD
Progesterone—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.67e-05	0.000381	CcSEcCtD
Progesterone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.67e-05	0.00038	CcSEcCtD
Progesterone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.66e-05	0.00038	CcSEcCtD
Progesterone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.00038	CcSEcCtD
Progesterone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.65e-05	0.00038	CcSEcCtD
Progesterone—Rash—Stavudine—acquired immunodeficiency syndrome	7.65e-05	0.000379	CcSEcCtD
Progesterone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.64e-05	0.000379	CcSEcCtD
Progesterone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.64e-05	0.000379	CcSEcCtD
Progesterone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000379	CcSEcCtD
Progesterone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000378	CcSEcCtD
Progesterone—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.62e-05	0.000378	CcSEcCtD
Progesterone—ABCB1—brain—acquired immunodeficiency syndrome	7.62e-05	0.00137	CbGeAlD
Progesterone—Headache—Stavudine—acquired immunodeficiency syndrome	7.6e-05	0.000377	CcSEcCtD
Progesterone—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.6e-05	0.000377	CcSEcCtD
Progesterone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000376	CcSEcCtD
Progesterone—Pain—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000376	CcSEcCtD
Progesterone—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000376	CcSEcCtD
Progesterone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.58e-05	0.000376	CcSEcCtD
Progesterone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.57e-05	0.000375	CcSEcCtD
Progesterone—Rash—Abacavir—acquired immunodeficiency syndrome	7.54e-05	0.000374	CcSEcCtD
Progesterone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.53e-05	0.000373	CcSEcCtD
Progesterone—Oedema—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000373	CcSEcCtD
Progesterone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000373	CcSEcCtD
Progesterone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.52e-05	0.000373	CcSEcCtD
Progesterone—Headache—Abacavir—acquired immunodeficiency syndrome	7.49e-05	0.000371	CcSEcCtD
Progesterone—Infection—Lamivudine—acquired immunodeficiency syndrome	7.48e-05	0.000371	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	7.47e-05	0.00037	CcSEcCtD
Progesterone—Nausea—Nevirapine—acquired immunodeficiency syndrome	7.46e-05	0.00037	CcSEcCtD
Progesterone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	7.46e-05	0.00037	CcSEcCtD
Progesterone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	7.41e-05	0.000368	CcSEcCtD
Progesterone—Shock—Lamivudine—acquired immunodeficiency syndrome	7.41e-05	0.000367	CcSEcCtD
Progesterone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000366	CcSEcCtD
Progesterone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.000366	CcSEcCtD
Progesterone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	7.36e-05	0.000365	CcSEcCtD
Progesterone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	7.36e-05	0.000365	CcSEcCtD
Progesterone—ABCB1—lymph node—acquired immunodeficiency syndrome	7.36e-05	0.00132	CbGeAlD
Progesterone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	7.32e-05	0.000363	CcSEcCtD
Progesterone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	7.32e-05	0.000363	CcSEcCtD
Progesterone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.31e-05	0.000363	CcSEcCtD
Progesterone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	7.31e-05	0.000363	CcSEcCtD
Progesterone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.000362	CcSEcCtD
Progesterone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	7.29e-05	0.000362	CcSEcCtD
Progesterone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000361	CcSEcCtD
Progesterone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	7.25e-05	0.00036	CcSEcCtD
Progesterone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.23e-05	0.000359	CcSEcCtD
Progesterone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	7.23e-05	0.000358	CcSEcCtD
Progesterone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000358	CcSEcCtD
Progesterone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	7.21e-05	0.000358	CcSEcCtD
Progesterone—Nausea—Stavudine—acquired immunodeficiency syndrome	7.21e-05	0.000357	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	7.19e-05	0.000357	CcSEcCtD
Progesterone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000356	CcSEcCtD
Progesterone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000354	CcSEcCtD
Progesterone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.13e-05	0.000354	CcSEcCtD
Progesterone—Nausea—Abacavir—acquired immunodeficiency syndrome	7.1e-05	0.000352	CcSEcCtD
Progesterone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000351	CcSEcCtD
Progesterone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.000351	CcSEcCtD
Progesterone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.000351	CcSEcCtD
Progesterone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	7.04e-05	0.000349	CcSEcCtD
Progesterone—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.04e-05	0.000349	CcSEcCtD
Progesterone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	7.03e-05	0.000349	CcSEcCtD
Progesterone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000349	CcSEcCtD
Progesterone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000348	CcSEcCtD
Progesterone—Pain—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000348	CcSEcCtD
Progesterone—Constipation—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000348	CcSEcCtD
Progesterone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	7.01e-05	0.000348	CcSEcCtD
Progesterone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	7.01e-05	0.000348	CcSEcCtD
Progesterone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.97e-05	0.000346	CcSEcCtD
Progesterone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000345	CcSEcCtD
Progesterone—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.94e-05	0.000344	CcSEcCtD
Progesterone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.86e-05	0.00034	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.86e-05	0.00034	CcSEcCtD
Progesterone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.83e-05	0.000339	CcSEcCtD
Progesterone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000338	CcSEcCtD
Progesterone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000338	CcSEcCtD
Progesterone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.000337	CcSEcCtD
Progesterone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.000335	CcSEcCtD
Progesterone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000335	CcSEcCtD
Progesterone—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000335	CcSEcCtD
Progesterone—Pain—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000335	CcSEcCtD
Progesterone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000333	CcSEcCtD
Progesterone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000333	CcSEcCtD
Progesterone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.7e-05	0.000333	CcSEcCtD
Progesterone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.7e-05	0.000333	CcSEcCtD
Progesterone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000332	CcSEcCtD
Progesterone—Rash—Zidovudine—acquired immunodeficiency syndrome	6.65e-05	0.00033	CcSEcCtD
Progesterone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.65e-05	0.00033	CcSEcCtD
Progesterone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.64e-05	0.000329	CcSEcCtD
Progesterone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000329	CcSEcCtD
Progesterone—Headache—Zidovudine—acquired immunodeficiency syndrome	6.61e-05	0.000328	CcSEcCtD
Progesterone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.56e-05	0.000325	CcSEcCtD
Progesterone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000325	CcSEcCtD
Progesterone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.53e-05	0.000324	CcSEcCtD
Progesterone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.51e-05	0.000323	CcSEcCtD
Progesterone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000323	CcSEcCtD
Progesterone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000322	CcSEcCtD
Progesterone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000322	CcSEcCtD
Progesterone—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.48e-05	0.000322	CcSEcCtD
Progesterone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6.48e-05	0.000321	CcSEcCtD
Progesterone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.48e-05	0.000321	CcSEcCtD
Progesterone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.45e-05	0.00032	CcSEcCtD
Progesterone—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000319	CcSEcCtD
Progesterone—Pain—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000319	CcSEcCtD
Progesterone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.36e-05	0.000316	CcSEcCtD
Progesterone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000314	CcSEcCtD
Progesterone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.27e-05	0.000311	CcSEcCtD
Progesterone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	6.27e-05	0.000311	CcSEcCtD
Progesterone—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.26e-05	0.000311	CcSEcCtD
Progesterone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000309	CcSEcCtD
Progesterone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000309	CcSEcCtD
Progesterone—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.24e-05	0.000309	CcSEcCtD
Progesterone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000308	CcSEcCtD
Progesterone—Rash—Indinavir—acquired immunodeficiency syndrome	6.18e-05	0.000307	CcSEcCtD
Progesterone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.18e-05	0.000306	CcSEcCtD
Progesterone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.16e-05	0.000305	CcSEcCtD
Progesterone—Headache—Indinavir—acquired immunodeficiency syndrome	6.14e-05	0.000305	CcSEcCtD
Progesterone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	6.13e-05	0.000304	CcSEcCtD
Progesterone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000301	CcSEcCtD
Progesterone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.0003	CcSEcCtD
Progesterone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.98e-05	0.000297	CcSEcCtD
Progesterone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.95e-05	0.000295	CcSEcCtD
Progesterone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.95e-05	0.000295	CcSEcCtD
Progesterone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.89e-05	0.000292	CcSEcCtD
Progesterone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.88e-05	0.000292	CcSEcCtD
Progesterone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.86e-05	0.000291	CcSEcCtD
Progesterone—Rash—Efavirenz—acquired immunodeficiency syndrome	5.84e-05	0.00029	CcSEcCtD
Progesterone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.84e-05	0.00029	CcSEcCtD
Progesterone—Nausea—Indinavir—acquired immunodeficiency syndrome	5.82e-05	0.000289	CcSEcCtD
Progesterone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.81e-05	0.000288	CcSEcCtD
Progesterone—Headache—Efavirenz—acquired immunodeficiency syndrome	5.8e-05	0.000288	CcSEcCtD
Progesterone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000288	CcSEcCtD
Progesterone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.66e-05	0.000281	CcSEcCtD
Progesterone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.64e-05	0.00028	CcSEcCtD
Progesterone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000278	CcSEcCtD
Progesterone—Rash—Delavirdine—acquired immunodeficiency syndrome	5.59e-05	0.000277	CcSEcCtD
Progesterone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000277	CcSEcCtD
Progesterone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.58e-05	0.000277	CcSEcCtD
Progesterone—Headache—Delavirdine—acquired immunodeficiency syndrome	5.55e-05	0.000275	CcSEcCtD
Progesterone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.55e-05	0.000275	CcSEcCtD
Progesterone—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.5e-05	0.000273	CcSEcCtD
Progesterone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.42e-05	0.000269	CcSEcCtD
Progesterone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.4e-05	0.000268	CcSEcCtD
Progesterone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000268	CcSEcCtD
Progesterone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.33e-05	0.000264	CcSEcCtD
Progesterone—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.27e-05	0.000261	CcSEcCtD
Progesterone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.000259	CcSEcCtD
Progesterone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000259	CcSEcCtD
Progesterone—Rash—Ritonavir—acquired immunodeficiency syndrome	5.17e-05	0.000256	CcSEcCtD
Progesterone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000256	CcSEcCtD
Progesterone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000255	CcSEcCtD
Progesterone—Headache—Ritonavir—acquired immunodeficiency syndrome	5.14e-05	0.000255	CcSEcCtD
Progesterone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.02e-05	0.000249	CcSEcCtD
Progesterone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000247	CcSEcCtD
Progesterone—Rash—Saquinavir—acquired immunodeficiency syndrome	4.98e-05	0.000247	CcSEcCtD
Progesterone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.97e-05	0.000247	CcSEcCtD
Progesterone—Headache—Saquinavir—acquired immunodeficiency syndrome	4.94e-05	0.000245	CcSEcCtD
Progesterone—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.87e-05	0.000242	CcSEcCtD
Progesterone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.79e-05	0.000237	CcSEcCtD
Progesterone—Rash—Lamivudine—acquired immunodeficiency syndrome	4.75e-05	0.000235	CcSEcCtD
Progesterone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000235	CcSEcCtD
Progesterone—Headache—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.000234	CcSEcCtD
Progesterone—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.69e-05	0.000232	CcSEcCtD
Progesterone—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.47e-05	0.000222	CcSEcCtD
Progesterone—AR—Notch-mediated HES/HEY network—CD4—acquired immunodeficiency syndrome	5.49e-06	0.00739	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	5.48e-06	0.00737	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	5.42e-06	0.00729	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	5.36e-06	0.0072	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	5.34e-06	0.00718	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	5.28e-06	0.00709	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	5.27e-06	0.00709	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	5.19e-06	0.00698	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	5.16e-06	0.00694	CbGpPWpGaD
Progesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	5.13e-06	0.00689	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	5.05e-06	0.00679	CbGpPWpGaD
Progesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	4.99e-06	0.0067	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	4.96e-06	0.00666	CbGpPWpGaD
Progesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	4.82e-06	0.00648	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	4.8e-06	0.00645	CbGpPWpGaD
Progesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	4.75e-06	0.00638	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.72e-06	0.00634	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	4.65e-06	0.00625	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	4.57e-06	0.00615	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	4.57e-06	0.00614	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	4.29e-06	0.00577	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	4.29e-06	0.00577	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	4.26e-06	0.00573	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—TAT—acquired immunodeficiency syndrome	4.19e-06	0.00563	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.17e-06	0.00561	CbGpPWpGaD
Progesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	4.14e-06	0.00556	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	4.08e-06	0.00549	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.97e-06	0.00533	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.97e-06	0.00533	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	3.93e-06	0.00529	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	3.85e-06	0.00518	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	3.85e-06	0.00517	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	3.77e-06	0.00507	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	3.71e-06	0.00498	CbGpPWpGaD
Progesterone—ESR1—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	3.65e-06	0.00491	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	3.62e-06	0.00487	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	3.62e-06	0.00487	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	3.57e-06	0.00481	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.56e-06	0.00479	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.54e-06	0.00476	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	3.54e-06	0.00475	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.43e-06	0.00462	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.43e-06	0.00461	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	3.39e-06	0.00455	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	3.36e-06	0.00452	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	3.27e-06	0.00439	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	3.26e-06	0.00438	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	3.19e-06	0.00428	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	3.14e-06	0.00422	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.1e-06	0.00417	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.1e-06	0.00417	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.08e-06	0.00414	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.06e-06	0.00412	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	3.03e-06	0.00407	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	2.98e-06	0.00401	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.95e-06	0.00397	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	2.94e-06	0.00396	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	2.9e-06	0.0039	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	2.89e-06	0.00388	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	2.88e-06	0.00387	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	2.88e-06	0.00387	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	2.83e-06	0.00381	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	2.81e-06	0.00378	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	2.79e-06	0.00375	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	2.77e-06	0.00372	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	2.76e-06	0.0037	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.67e-06	0.00359	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	2.62e-06	0.00353	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.62e-06	0.00352	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.6e-06	0.0035	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.6e-06	0.0035	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	2.58e-06	0.00347	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	2.58e-06	0.00346	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.53e-06	0.0034	CbGpPWpGaD
Progesterone—PGR—Gene Expression—CCNT1—acquired immunodeficiency syndrome	2.48e-06	0.00334	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	2.48e-06	0.00334	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.48e-06	0.00333	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	2.47e-06	0.00332	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	2.46e-06	0.0033	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.33e-06	0.00314	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.3e-06	0.0031	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.19e-06	0.00295	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.19e-06	0.00295	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.19e-06	0.00294	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	2.19e-06	0.00294	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.14e-06	0.00288	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.11e-06	0.00284	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	2.1e-06	0.00282	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.09e-06	0.00281	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	1.97e-06	0.00265	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	1.94e-06	0.0026	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.93e-06	0.0026	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.91e-06	0.00257	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.91e-06	0.00257	CbGpPWpGaD
Progesterone—ESR1—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	1.91e-06	0.00257	CbGpPWpGaD
Progesterone—AR—Gene Expression—CCNT1—acquired immunodeficiency syndrome	1.89e-06	0.00255	CbGpPWpGaD
Progesterone—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.89e-06	0.00254	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.88e-06	0.00253	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	1.86e-06	0.00249	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	1.79e-06	0.00241	CbGpPWpGaD
Progesterone—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.77e-06	0.00238	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.73e-06	0.00232	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.67e-06	0.00225	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.67e-06	0.00224	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	1.66e-06	0.00224	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.64e-06	0.00221	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	1.64e-06	0.0022	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	1.62e-06	0.00218	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.62e-06	0.00217	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.62e-06	0.00217	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.62e-06	0.00217	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.58e-06	0.00212	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.57e-06	0.00212	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	1.57e-06	0.0021	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.53e-06	0.00206	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.53e-06	0.00205	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	1.53e-06	0.00205	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.51e-06	0.00202	CbGpPWpGaD
Progesterone—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	1.51e-06	0.00202	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.5e-06	0.00202	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TAT—acquired immunodeficiency syndrome	1.48e-06	0.00199	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.46e-06	0.00196	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	1.46e-06	0.00196	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	1.44e-06	0.00194	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	1.44e-06	0.00193	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.41e-06	0.0019	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	1.38e-06	0.00185	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.37e-06	0.00185	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.36e-06	0.00183	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.35e-06	0.00181	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.32e-06	0.00178	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.32e-06	0.00177	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.28e-06	0.00172	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.27e-06	0.0017	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.27e-06	0.0017	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.26e-06	0.0017	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.24e-06	0.00167	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.24e-06	0.00167	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—TNF—acquired immunodeficiency syndrome	1.24e-06	0.00166	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.22e-06	0.00164	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.22e-06	0.00164	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.2e-06	0.00162	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.2e-06	0.00161	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.2e-06	0.00161	CbGpPWpGaD
Progesterone—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.18e-06	0.00159	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.17e-06	0.00157	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.14e-06	0.00154	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.14e-06	0.00153	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.13e-06	0.00151	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.13e-06	0.00151	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.11e-06	0.00149	CbGpPWpGaD
Progesterone—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.1e-06	0.00148	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.07e-06	0.00144	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.01e-06	0.00136	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—IL6—acquired immunodeficiency syndrome	9.99e-07	0.00134	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.98e-07	0.00134	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	9.95e-07	0.00134	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	9.91e-07	0.00133	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.67e-07	0.0013	CbGpPWpGaD
Progesterone—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.59e-07	0.00129	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.48e-07	0.00127	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.48e-07	0.00127	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.43e-07	0.00127	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	9.4e-07	0.00126	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.29e-07	0.00125	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.24e-07	0.00124	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	9.04e-07	0.00122	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.03e-07	0.00121	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	8.95e-07	0.0012	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	8.83e-07	0.00119	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	8.63e-07	0.00116	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	8.62e-07	0.00116	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.58e-07	0.00115	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.56e-07	0.00115	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.49e-07	0.00114	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.49e-07	0.00114	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.49e-07	0.00114	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.43e-07	0.00113	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	8.32e-07	0.00112	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	8.25e-07	0.00111	CbGpPWpGaD
Progesterone—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	7.91e-07	0.00106	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.82e-07	0.00105	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.71e-07	0.00104	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	7.69e-07	0.00103	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.51e-07	0.00101	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—ALB—acquired immunodeficiency syndrome	7.31e-07	0.000982	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.27e-07	0.000977	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	7.07e-07	0.000951	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.07e-07	0.00095	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	7.05e-07	0.000947	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.03e-07	0.000945	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.01e-07	0.000943	CbGpPWpGaD
Progesterone—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.91e-07	0.000929	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.65e-07	0.000894	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.65e-07	0.000894	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.46e-07	0.000868	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.36e-07	0.000855	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.02e-07	0.000809	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.99e-07	0.000805	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.86e-07	0.000788	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.82e-07	0.000782	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.61e-07	0.000754	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	5.44e-07	0.000731	CbGpPWpGaD
Progesterone—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	5.42e-07	0.000729	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.36e-07	0.000721	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.3e-07	0.000712	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.06e-07	0.00068	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.98e-07	0.00067	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.98e-07	0.00067	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.98e-07	0.00067	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.91e-07	0.00066	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.89e-07	0.000657	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.62e-07	0.000622	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.56e-07	0.000612	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	4.49e-07	0.000604	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.46e-07	0.000599	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.33e-07	0.000582	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	4.31e-07	0.000579	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.97e-07	0.000533	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.79e-07	0.000509	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.73e-07	0.000502	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.54e-07	0.000476	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.41e-07	0.000459	CbGpPWpGaD
Progesterone—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	3.4e-07	0.000458	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.36e-07	0.000452	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.29e-07	0.000442	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	3.24e-07	0.000435	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.23e-07	0.000434	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	3.13e-07	0.000421	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.82e-07	0.000379	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.82e-07	0.000379	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.76e-07	0.000371	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.63e-07	0.000354	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.63e-07	0.000353	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.62e-07	0.000352	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	2.59e-07	0.000348	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	2.04e-07	0.000274	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.98e-07	0.000266	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.97e-07	0.000265	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.93e-07	0.000259	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	1.84e-07	0.000248	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.77e-07	0.000238	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.58e-07	0.000212	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.55e-07	0.000208	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.54e-07	0.000207	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.45e-07	0.000195	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.44e-07	0.000193	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.23e-07	0.000165	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.16e-07	0.000156	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	9.48e-08	0.000127	CbGpPWpGaD
